Revvity, Inc. provides products and services primarily to the diagnostics, life sciences, and applied services markets. It operates through two main segments: Discovery & Analytical Solutions, contributing approximately 60% of revenue, and Diagnostics, accounting for about 40%. The Discovery & Analytical Solutions segment offers instruments, reagents, software, and laboratory services for life sciences and environmental analysis, while the Diagnostics segment focuses on instruments and assays for genetic and infectious disease testing. Revenue is generated from pharmaceutical companies, laboratories, academic institutions, and healthcare organizations. Factors supporting endurance include a diverse product portfolio and established customer relationships, while potential limitations may arise from regulatory changes and competition in the diagnostics field.
—
Revvity, Inc. provides products and services primarily to the diagnostics, life sciences, and applied services markets. It operates through two main segments: Discovery & Analytical Solutions, contributing approximately 60% of revenue, and Diagnostics, accounting for about 40%. The Discovery & Analytical Solutions segment offers instruments, reagents, software, and laboratory services for life sciences and environmental analysis, while the Diagnostics segment focuses on instruments and assays for genetic and infectious disease testing. Revenue is generated from pharmaceutical companies, laboratories, academic institutions, and healthcare organizations. Factors supporting endurance include a diverse product portfolio and established customer relationships, while potential limitations may arise from regulatory changes and competition in the diagnostics field.
—
Daily adjusted close
Revvity, Inc. provides products and services primarily to the diagnostics, life sciences, and applied services markets. It operates through two main segments: Discovery & Analytical Solutions, contributing approximately 60% of revenue, and Diagnostics, accounting for about 40%. The Discovery & Analytical Solutions segment offers instruments, reagents, software, and laboratory services for life sciences and environmental analysis, while the Diagnostics segment focuses on instruments and assays for genetic and infectious disease testing. Revenue is generated from pharmaceutical companies, laboratories, academic institutions, and healthcare organizations. Factors supporting endurance include a diverse product portfolio and established customer relationships, while potential limitations may arise from regulatory changes and competition in the diagnostics field.